Bridgeway Capital Management’s Traws Pharma TRAW Stock Holding History

Bridgeway Capital Management’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-38	Closed	-$30K	–	1411
2018 Q4	$30K	Buy	+38	New	+$64.8K	﹤0.01%	1353
2017 Q3	–	Sell	-3	Closed	-$36K	–	1453
2017 Q2	$36K	Hold	3	–	–	﹤0.01%	1397
2017 Q1	$51K	Buy	+3	New	+$46.6K	﹤0.01%	1364
2016 Q2	–	Hold	0	–	-$7K	–	1486
2016 Q1	–	Hold	0	–	–	–	1425
2015 Q4	–	Hold	0	–	–	–	1423
2015 Q3	–	Hold	0	–	–	–	1454
2015 Q2	–	Hold	0	–	–	–	1481
2015 Q1	–	Hold	0	–	–	–	1467
2014 Q4	–	Hold	0	–	–	–	1440
2014 Q3	–	Hold	0	–	–	–	1457
2014 Q2	–	Sell	-1	Closed	-$295K	–	1415
2014 Q1	$298K	Buy	+1	New	+$602K	0.01%	1246

Other funds holding TRAW

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

TCP

Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PFGIA

Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bridgeway Capital Management's TRAW Position: Q1 2019 in Review

Bridgeway Capital Management sold out of Traws Pharma (TRAW) in Q1 2019, closing a stake of 38 shares — an estimated $30K sold.

Bridgeway Capital Management first reported a position in TRAW in Q1 2014 and held it in 4 quarters. The position peaked at $298K in Q1 2014. 12 funds tracked by Wall St. Rank hold TRAW as of Q1 2019.

Bridgeway Capital Management reported no remaining Traws Pharma position as of Q1 2019 after selling out during the quarter.
Bridgeway Capital Management sold 38 Traws Pharma shares in Q1 2019, an estimated $30K.
Bridgeway Capital Management first reported a position in Traws Pharma in Q1 2014 and held it in 4 quarters.
Bridgeway Capital Management's Traws Pharma position peaked at $298K in Q1 2014.
12 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2019.

Based on Bridgeway Capital Management's 13F filing for Q1 2019, filed 15 May 2019.